(UT Southwestern Medical Center) Patients with diabetes, kidney disease and anemia who don't respond to treatment with an anti-anemia drug have a higher risk of cardiovascular disease or death, researchers at UT Southwestern Medical Center have found.
anemia drugPoor response to anti-anemia drug predicts higher risk of heart ...EurekAlert! - Medicine and Health Tue, 12/28/2010 - 23:00
Study finds stroke risk from anemia drug AranespHeadlines from the Associated Press Fri, 10/30/2009 - 18:40
A new study raises fresh safety concerns about widely used anemia medicines, finding that the drug Aranesp nearly doubled the risk of stroke in people with diabetes and chronic kidney problems who are not yet sick enough to need dialysis.... |
